Dr. Arvind Nirula, M.D

NPI: 1437285095
Total Payments
$20,973
2024 Payments
$2,593
Companies
46
Transactions
585
Medicare Patients
6,080
Medicare Billing
$747,798

Payment Breakdown by Category

Food & Beverage$17,399 (83.0%)
Travel$3,547 (16.9%)
Education$26.77 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $17,399 577 83.0%
Travel and Lodging $3,547 5 16.9%
Education $26.77 3 0.1%

Top Paying Companies

Company Total Records Latest Year
Edwards Lifesciences Corporation $3,865 22 $0 (2024)
Medtronic Vascular, Inc. $1,997 20 $0 (2020)
Abbott Laboratories $1,510 31 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $1,442 31 $0 (2024)
PFIZER INC. $1,075 84 $0 (2024)
Novartis Pharmaceuticals Corporation $1,008 57 $0 (2024)
E.R. Squibb & Sons, L.L.C. $967.79 38 $0 (2023)
Inari Medical, Inc. $862.65 8 $0 (2024)
BIOTRONIK INC. $709.09 10 $0 (2024)
Janssen Pharmaceuticals, Inc $622.34 36 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,593 92 Inari Medical, Inc. ($267.80)
2023 $5,866 89 Edwards Lifesciences Corporation ($3,166)
2022 $2,736 90 Edwards Lifesciences Corporation ($319.21)
2021 $2,260 54 BIOTRONIK INC. ($413.97)
2020 $634.04 30 PFIZER INC. ($156.72)
2019 $2,314 94 Abbott Laboratories ($425.77)
2018 $1,758 73 PFIZER INC. ($253.17)
2017 $2,813 63 Medtronic Vascular, Inc. ($1,565)

All Payment Transactions

585 individual payment records from CMS Open Payments — Page 1 of 24

Date Company Product Nature Form Amount Type
12/17/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $22.52 General
Category: Cardiology
12/10/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $19.00 General
Category: CARDIOVASCULAR
12/09/2024 CARDIVA MEDICAL, INC. CARDIVA VASCADE MVP VVCS 6-12F (Device) Food and Beverage In-kind items and services $18.64 General
Category: DEVICES
12/04/2024 ShockWave Medical, Inc Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) Food and Beverage In-kind items and services $222.94 General
Category: Lithoplasty
11/26/2024 Alnylam Pharmaceuticals Inc. AMVUTTRA (Drug) Food and Beverage In-kind items and services $22.07 General
Category: Genetic Disease
11/21/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $125.00 General
Category: Electromedical and Electrotherapeutic Apparatus
11/19/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $21.89 General
Category: DIABETES
11/19/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $19.33 General
Category: Cardiology
11/07/2024 CARDIVA MEDICAL, INC. SAVVYWIRE (Device) Food and Beverage In-kind items and services $23.67 General
Category: DEVICES
11/07/2024 Edwards Lifesciences Corporation SAPIEN 3 Ultra RESILIA (Device) Food and Beverage In-kind items and services $3.54 General
Category: Transcatheter Heart Valves
11/05/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $18.62 General
Category: Cardiology/Vascular Diseases
11/01/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $8.44 General
Category: Electromedical and Electrotherapeutic Apparatus
10/31/2024 ATRICURE, INC. ATRICLIP LAA EXCLUSION SYSTEM (Device) Food and Beverage In-kind items and services $11.63 General
Category: CARDIOVASCULAR
10/24/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $1.38 General
Category: Electromedical and Electrotherapeutic Apparatus
10/22/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $31.08 General
Category: Diabetes
10/17/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $19.43 General
Category: Electromedical and Electrotherapeutic Apparatus
10/15/2024 Alnylam Pharmaceuticals Inc. AMVUTTRA (Drug) Food and Beverage In-kind items and services $22.57 General
Category: Genetic Disease
10/11/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $23.32 General
Category: Cardiology
10/10/2024 Edwards Lifesciences Corporation SAPIEN 3 Ultra RESILIA (Device) Food and Beverage In-kind items and services $26.92 General
Category: Transcatheter Heart Valves
10/09/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $1.62 General
Category: Electromedical and Electrotherapeutic Apparatus
10/08/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $29.47 General
Category: Cardiology
10/08/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $29.47 General
Category: Cardiology
10/04/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $9.69 General
Category: Electromedical and Electrotherapeutic Apparatus
09/26/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $25.50 General
Category: DIABETES
09/24/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $13.29 General
Category: Electromedical and Electrotherapeutic Apparatus

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 25 1,838 2,752 $578,585 $214,222
2022 20 1,855 2,681 $567,133 $209,707
2021 18 1,347 2,062 $428,345 $179,702
2020 20 1,040 1,641 $316,353 $144,166
Total Patients
6,080
Total Services
9,136
Medicare Billing
$747,798
Procedure Codes
87

All Medicare Procedures & Services

87 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 370 763 $120,554 $76,441 63.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 121 244 $61,000 $24,243 39.7%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 121 134 $92,880 $23,217 25.0%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Office 2023 32 32 $35,200 $13,089 37.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 86 91 $25,025 $12,240 48.9%
93970 Ultrasound study of arm or leg veins with compression and maneuvers Office 2023 46 46 $20,700 $8,088 39.1%
J2785 Injection, regadenoson, 0.1 mg Office 2023 40 160 $16,800 $7,480 44.5%
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose Office 2023 45 89 $71,200 $6,494 9.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 48 48 $9,725 $6,157 63.3%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Facility 2023 82 86 $20,640 $4,852 23.5%
93880 Ultrasound of both sides of head and neck blood flow Office 2023 24 26 $11,830 $4,436 37.5%
93015 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician Office 2023 67 67 $17,755 $4,256 24.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 293 344 $17,200 $4,010 23.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 19 21 $6,300 $3,316 52.6%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2023 12 69 $10,350 $3,282 31.7%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2023 11 70 $8,050 $3,051 37.9%
93351 Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report Office 2023 11 11 $8,800 $2,369 26.9%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 285 311 $4,301 $2,076 48.3%
93454 Insertion of tube in coronary artery for diagnosis with review by radiologist Facility 2023 11 14 $9,100 $1,956 21.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 21 27 $3,105 $1,799 57.9%
93228 Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional Office 2023 14 14 $1,260 $305.76 24.3%
93325 Ultrasound of heart with color-depicted blood flow, rate and valve function Office 2023 11 11 $2,200 $245.19 11.1%
76937 Ultrasonic guidance for blood vessel access Facility 2023 18 21 $910.00 $238.00 26.2%
99152 Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes Facility 2023 18 21 $420.00 $209.40 49.9%
93225 Electrocardiogram (ecg) 2-day continuous Office 2023 16 16 $1,760 $193.49 11.0%

About Dr. Arvind Nirula, M.D

Dr. Arvind Nirula, M.D is a Cardiovascular Disease healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437285095.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arvind Nirula, M.D has received a total of $20,973 in payments from pharmaceutical and medical device companies, with $2,593 received in 2024. These payments were reported across 585 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($17,399).

As a Medicare-enrolled provider, Nirula has provided services to 6,080 Medicare beneficiaries, totaling 9,136 services with total Medicare billing of $747,798. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Location Fountain Valley, CA
  • Active Since 02/26/2007
  • Last Updated 11/09/2020
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1437285095

Products in Payments

  • EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $2,871
  • ClosureFast (Device) $1,565
  • LifeVest (Device) $1,442
  • ELIQUIS (Drug) $1,424
  • FLOWTRIEVER CATHETER, S (Device) $862.65
  • XARELTO (Drug) $699.44
  • ENTRESTO (Drug) $650.96
  • VERQUVO (Drug) $577.91
  • Impella (Device) $572.94
  • Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $517.49
  • SAPIEN 3 Ultra RESILIA (Device) $476.76
  • JARDIANCE (Drug) $422.17
  • Repatha (Biological) $364.32
  • MULTAQ (Drug) $357.99
  • LEQVIO (Drug) $357.45
  • Confirm Rx (Device) $337.11
  • Assure WCD (Device) $310.36
  • CAMZYOS (Drug) $289.25
  • Vascular Lithotripsy (Device) $261.59
  • FARXIGA (Drug) $258.94

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Fountain Valley